These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 30888584

  • 41. Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23.
    Mazzaferro S, Pasquali M, Pugliese F, Citterio F, Gargiulo A, Rotondi S, Tartaglione L, Conte C, Pirrò G, Taggi F.
    J Nephrol; 2012; 25(6):1108-18. PubMed ID: 22383345
    [Abstract] [Full Text] [Related]

  • 42. Cholecalciferol supplementation and angiogenic markers in chronic kidney disease.
    Kaur J, Kamboj K, Yadav AK, Kaur P, Kumar V, Jha V.
    PLoS One; 2022; 17(6):e0268946. PubMed ID: 35657784
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Effects of Cholecalciferol vs Calcifediol on Total and Free 25-Hydroxyvitamin D and Parathyroid Hormone.
    Shieh A, Ma C, Chun RF, Witzel S, Rafison B, Contreras HTM, Wittwer-Schegg J, Swinkels L, Huijs T, Hewison M, Adams JS.
    J Clin Endocrinol Metab; 2017 Apr 01; 102(4):1133-1140. PubMed ID: 28187226
    [Abstract] [Full Text] [Related]

  • 45. The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.
    Salekzamani S, Bavil AS, Mehralizadeh H, Jafarabadi MA, Ghezel A, Gargari BP.
    Endocrine; 2017 Jul 01; 57(1):51-59. PubMed ID: 28509078
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Activation of FGF-23 mediated vitamin D degradative pathways by cholecalciferol.
    Alshayeb H, Showkat A, Wall BM, Gyamlani GG, David V, Quarles LD.
    J Clin Endocrinol Metab; 2014 Oct 01; 99(10):E1830-7. PubMed ID: 24960544
    [Abstract] [Full Text] [Related]

  • 49. Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients.
    Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D.
    PLoS One; 2014 Oct 01; 9(3):e91363. PubMed ID: 24646518
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2010 Aug 01; 58(8):1489-95. PubMed ID: 20646099
    [Abstract] [Full Text] [Related]

  • 53. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
    Nahas-Neto J, Cangussu LM, Orsatti CL, Bueloni-Dias FN, Poloni PF, Schmitt EB, Nahas EAP.
    Osteoporos Int; 2018 May 01; 29(5):1125-1133. PubMed ID: 29450585
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Improvement of vitamin D status in Japanese institutionalized elderly by supplementation with 800 IU of vitamin D(3).
    Kuwabara A, Tsugawa N, Tanaka K, Fujii M, Kawai N, Mukae S, Kato Y, Kojima Y, Takahashi K, Omura K, Kagawa R, Inoue A, Noike T, Kido S, Okano T.
    J Nutr Sci Vitaminol (Tokyo); 2009 Dec 01; 55(6):453-8. PubMed ID: 20086314
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Clinical value of two methods to measure parathyroid hormone in chronic renal insufficiency, considering vitamin D metabolism].
    Kovács L, Virágh E, Balogh D, Kálmán B, Lőcsei Z, Toldy E.
    Orv Hetil; 2013 Dec 22; 154(51):2025-36. PubMed ID: 24334134
    [Abstract] [Full Text] [Related]

  • 58. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration.
    Grant CC, Stewart AW, Scragg R, Milne T, Rowden J, Ekeroma A, Wall C, Mitchell EA, Crengle S, Trenholme A, Crane J, Camargo CA.
    Pediatrics; 2014 Jan 22; 133(1):e143-53. PubMed ID: 24344104
    [Abstract] [Full Text] [Related]

  • 59. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol.
    Glendenning P, Chew GT, Seymour HM, Gillett MJ, Goldswain PR, Inderjeeth CA, Vasikaran SD, Taranto M, Musk AA, Fraser WD.
    Bone; 2009 Nov 22; 45(5):870-5. PubMed ID: 19631774
    [Abstract] [Full Text] [Related]

  • 60. Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.
    Sprague SM, Silva AL, Al-Saghir F, Damle R, Tabash SP, Petkovich M, Messner EJ, White JA, Melnick JZ, Bishop CW.
    Am J Nephrol; 2014 Nov 22; 40(6):535-45. PubMed ID: 25572630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.